


Healthcare Industry News: HIV/AIDS
News Release - February 8, 2016
Sangamo BioSciences Announces FDA Clearance Of Investigational New Drug Application For ZFN-Mediated Genome Editing Treatment Of MPS I
Source: Sangamo BioSciences
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
